-
Mashup Score: 3
Lawmakers raising national security concerns and seeking to disconnect a major Chinese firm from U.S. pharmaceutical interests have rattled the biotech industry. The firm is deeply involved in development and manufacturing of crucial therapies for cancer, cystic fibrosis, H.I.V. and other illnesses.
Source: www.nytimes.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 69th Translational Research Conference: Myelodysplastic Syndromes | ESH - European School of Haematology - 18 day(s) ago
Chairs : Pierre Fenaux, Katharina Götze, Mikkael Sekeres SAVE THE DATE! April 12-14, 2024 – Budapest, Hungary Chairs: Pierre Fenaux, Katharina G ö tze, Mikkael Sekeres REGISTRATION & ABSTRACT SUBMISSION ARE OPEN! ABOUT THE CONFERENCE: ESH 9 th TRANSLATIONAL RESEARCH CONFERENCE ON MYELODYSPLASTIC SYNDROMES proposes a programme of leading-edge basic and clinical science, as well as opportunities for informal scientific interaction with a panel of global experts in the field. It is open to an international
Source: www.esh.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 10
Studies show that patients when cancer returns, patients often are quite willing to receive toxic treatments that promise minimal potential benefit.
Source: www.washingtonpost.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 21Who can sue the FDA? Answering Justice Alito's question from the mifepristone arguments - 30 day(s) ago
Supreme Court Justice Samuel Alito had a clear question at Tuesday’s arguments over the abortion pill mifepristone: If the doctors who brought that case can’t sue the FDA over a drug’s label, who can? And when?
Source: www.statnews.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 6
At face value, the “preventive chemotherapy” Princess Kate mentioned sounds like chemo to prevent cancer, but it’s more complex than that.
Source: www.usatoday.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 69th Translational Research Conference: Myelodysplastic Syndromes | ESH - European School of Haematology - 1 month(s) ago
Chairs : Pierre Fenaux, Katharina Götze, Mikkael Sekeres SAVE THE DATE! April 12-14, 2024 – Budapest, Hungary Chairs: Pierre Fenaux, Katharina G ö tze, Mikkael Sekeres REGISTRATION & ABSTRACT SUBMISSION ARE OPEN! ABOUT THE CONFERENCE: ESH 9 th TRANSLATIONAL RESEARCH CONFERENCE ON MYELODYSPLASTIC SYNDROMES proposes a programme of leading-edge basic and clinical science, as well as opportunities for informal scientific interaction with a panel of global experts in the field. It is open to an international
Source: www.esh.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1The Unbearable Vagueness of Medical ‘Professionalism’ - 1 month(s) ago
Since its inception, this murky term has straddled the dual role of disciplining and inspiring.
Source: www.nytimes.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 11Does FDA Withdrawal of Cancer Drug Show Bigger Changes Needed? - 2 month(s) ago
The recent withdrawal a cancer drug that had been granted accelerated approval by the FDA may be illustrative of concerns raised by some critics.
Source: www.obroncology.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 69th Translational Research Conference: Myelodysplastic Syndromes | ESH - European School of Haematology - 2 month(s) ago
Chairs : Pierre Fenaux, Katharina Götze, Mikkael Sekeres SAVE THE DATE! April 12-14, 2024 – Budapest, Hungary Chairs: Pierre Fenaux, Katharina G ö tze, Mikkael Sekeres REGISTRATION & ABSTRACT SUBMISSION ARE OPEN! ABOUT THE CONFERENCE: ESH 9 th TRANSLATIONAL RESEARCH CONFERENCE ON MYELODYSPLASTIC SYNDROMES proposes a programme of leading-edge basic and clinical science, as well as opportunities for informal scientific interaction with a panel of global experts in the field. It is open to an international
Source: www.esh.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 69th Translational Research Conference: Myelodysplastic Syndromes | ESH - European School of Haematology - 2 month(s) ago
Chairs : Pierre Fenaux, Katharina Götze, Mikkael Sekeres SAVE THE DATE! April 12-14, 2024 – Budapest, Hungary Chairs: Pierre Fenaux, Katharina G ö tze, Mikkael Sekeres REGISTRATION & ABSTRACT SUBMISSION ARE OPEN! ABOUT THE CONFERENCE: ESH 9 th TRANSLATIONAL RESEARCH CONFERENCE ON MYELODYSPLASTIC SYNDROMES proposes a programme of leading-edge basic and clinical science, as well as opportunities for informal scientific interaction with a panel of global experts in the field. It is open to an international
Source: www.esh.orgCategories: General Medicine News, Hem/OncsTweet
Superb reporting by @By_CJewett @nytimes on national security concerns about a company that makes key ingredients for #Cancer drugs. Appreciate the chance to contribute! @SylvesterCancer @UMiamiHealth https://t.co/lMj9xk1YnV